Kute V B, Godara S M, Goplani K R, Gumber M R, Shah P R, Vanikar A V, Shah V R, Trivedi H L
Department of Nephrology and Clinical Transplantation, Smt Gulabben Rasiklal Doshi and Smt Kamlaben Mafatlal Mehta Institute of Kidney Diseases & Research Centre, Dr. H. L. Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India.
Saudi J Kidney Dis Transpl. 2011 Jan;22(1):83-9.
Patients infected with H1N1 virus may develop pneumonia and acute kidney injury (AKI). To determine the epidemiological characteristics, clinical features, management and out-comes of patients with confirmed H1N1 complicated by pneumonia and AKI and treatment with oseltamivir and to identify the prognostic indicators, we studied all the patients with a confirmed diagnosis of H1N1 infection with pneumonia and AKI, using real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay, between October 2009 and March 2010. H1N1 infection was confirmed in 20 patients with pneumonia and AKI; the mean age was 42.8 ± 18.2 years and 12 (60%) of the patients were males. Eleven patients were between 15 and 50 years of age, and 15 had preexisting medical conditions. All patients had fever, cough, dyspnea or respiratory distress, increased serum lactate dehydrogenase levels, pneumonia and AKI. Fifteen (75%) patients required mechanical ventilation and 14 (70%) died. None of the health care workers developed influenza-like illness, when they received oseltamivir prophylaxis. Mortality was associated with higher Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment score (SOFA), Multiple Organ Dysfunction Score (MODS), XRChest score, in addition to requirement of inotrope, ventilator support, renal replacement therapy (RRT), and presence of underlying risk factor for severe disease.
感染H1N1病毒的患者可能会并发肺炎和急性肾损伤(AKI)。为了确定确诊为H1N1并发肺炎和AKI且接受奥司他韦治疗的患者的流行病学特征、临床特点、治疗及预后,并找出预后指标,我们对2009年10月至2010年3月期间所有确诊为H1N1感染并发肺炎和AKI的患者进行了研究,采用实时逆转录聚合酶链反应(RT-PCR)检测法。20例肺炎合并AKI患者确诊为H1N1感染;平均年龄为42.8±18.2岁,其中12例(60%)为男性。11例患者年龄在15至50岁之间,15例有基础疾病。所有患者均有发热、咳嗽、呼吸困难或呼吸窘迫、血清乳酸脱氢酶水平升高、肺炎和AKI。15例(75%)患者需要机械通气,14例(70%)死亡。医护人员在接受奥司他韦预防治疗后均未出现流感样疾病。除了需要使用血管活性药物、呼吸机支持、肾脏替代治疗(RRT)以及存在严重疾病的潜在危险因素外,死亡率还与较高的急性生理与慢性健康状况评分系统(APACHE)II、序贯器官衰竭评估评分(SOFA)、多器官功能障碍评分(MODS)、胸部X线评分相关。